Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture

por Krafft, U, Mahmoud, O, Hess, J, Radtke, J.P, Panic, A, Püllen, L, Darr, C, Kesch, C, Szarvas, T, Rehme, C, Hadaschik, B.A, Tschirdewahn, S
Publicado 2021

Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen

por Radtke, JP, Schwab, C, Wolf, MB, Freitag, MT, Alt, C, Kesch, C, Popeneciu, IV, Huettenbrink, C, Bergstraesser-Gasch, C, Klein, T, Duensing, S, Roth, S, Schlemmer, HP, Roethke, M, Hohenfellner, M, Hadaschik, B
Publicado 2015

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

por Dendl, K., Finck, R., Giesel, F. L., Kratochwil, C., Lindner, T., Mier, W., Cardinale, J., Kesch, C., Röhrich, M., Rathke, H., Gampp, H., Ristau, J., Adeberg, S., Jäger, D., Debus, J., Haberkorn, U., Koerber, S. A.
Publicado 2021

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

por Giesel, Frederik L., Hadaschik, B., Cardinale, J., Radtke, J., Vinsensia, M., Lehnert, W., Kesch, C., Tolstov, Y., Singer, S., Grabe, N., Duensing, S., Schäfer, M., Neels, O. C., Mier, W., Haberkorn, U., Kopka, K., Kratochwil, C.
Publicado 2016

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study

por Zattoni, F., Marra, G., Kretschmer, A., Preisser, F., Kesch, C., Radtke, J.P., Hoffmann, N., Morlacco, A., Dal Moro, F., Soeterik, T.F., Van Den Bergh, R.C., Barletta, F., Briganti, A., Montorisi, F., Gandaglia, G.
Publicado 2021